Back to Search Start Over

Impact of the COVID-19 pandemic on surgical care in the Netherlands

Authors :
De Graaff, Michelle R
Hogenbirk, Rianne N M
Janssen, Yester F
Elfrink, Arthur K E
Liem, Ronald S L
Nienhuijs, Simon W
De Vries, Jean Paul P M
Elshof, Jan Willem
Verdaasdonk, Emiel
Melenhorst, Jarno
Van Westreenen, H L
Besselink, Marc G H
Ruurda, Jelle P
Van Berge Henegouwen, Mark I
Klaase, Joost M
Den Dulk, Marcel
Van Heijl, Mark
Hegeman, Johannes H
Braun, Jerry
Voeten, Daan M
Würdemann, Franka S
Warps, Anne Loes K
Alberga, Anna J
Suurmeijer, J Annelie
Akpinar, Erman O
Wolfhagen, Nienke
Van Den Boom, Anne Loes
Bolster-van Eenennaam, Marieke J
Van Duijvendijk, Peter
Heineman, David J
Wouters, Michel W J M
Kruijff, Schelto
Helleman, J N
Koningswoud-terhoeve, C L
Belt, E
Van Der Hoeven, J A B
Marres, G M H
Tozzi, F
Von Meyenfeldt, E M
Coebergh, R R J
Van Den Braak, H.P.
Rijken, A M
Balm, R
Daams, F
Dickhoff, C
Eshuis, W J
Gisbertz, S S
Zandbergen, H R
Geelkerken, R H
Halfwerk, F R
Biomedical Signals and Systems
TechMed Centre
Multi-Modality Medical Imaging
Biomechanical Engineering
Engineering Organ Support Technologies
Digital Society Institute
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Surgery
MUMC+: MA Heelkunde (9)
RS: NUTRIM - R2 - Liver and digestive health
Cardiothoracic Surgery
Dermatology
Cancer Center Amsterdam
Cardio-thoracic surgery
Obstetrics and gynaecology
Amsterdam Reproduction & Development (AR&D)
CCA - Cancer Treatment and Quality of Life
CCA - Imaging and biomarkers
AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
Graduate School
​Robotics and image-guided minimally-invasive surgery (ROBOTICS)
Groningen Institute for Organ Transplantation (GIOT)
Value, Affordability and Sustainability (VALUE)
Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Source :
British journal of surgery, 109(12):znac301, 1282-1292. Wiley, British Journal of Surgery, 109, 1282-1292. Wiley, British Journal of Surgery, 109(12), 1282-1292. John Wiley & Sons Ltd., Dutch CovidSurg Collaborative Study Group 2022, ' Impact of the COVID-19 pandemic on surgical care in the Netherlands ', British Journal of Surgery, vol. 109, no. 12, pp. 1282-1292 . https://doi.org/10.1093/bjs/znac301, https://doi.org/10.1093/bjs/znac301, The British journal of surgery, 109(12), 1282-1292. John Wiley and Sons Ltd, British Journal of Surgery, 109(12), 1282-1292. OXFORD UNIV PRESS, British Journal of Surgery, 109(12). Wiley, British Journal of Surgery, 109(12), 1282-1292. John Wiley and Sons Ltd
Publication Year :
2022

Abstract

During the COVID-19 pandemic, a 13.6 per cent reduction in the number of surgical procedures performed was observed in 2020. Despite great pressure on healthcare, the COVID-19 pandemic did not cause an increase in adverse surgical outcomes, and oncological surgery-related duration of hospital and ICU stay were significantly shorter.Background The COVID-19 pandemic caused disruption of regular healthcare leading to reduced hospital attendances, repurposing of surgical facilities, and cancellation of cancer screening programmes. This study aimed to determine the impact of COVID-19 on surgical care in the Netherlands. Methods A nationwide study was conducted in collaboration with the Dutch Institute for Clinical Auditing. Eight surgical audits were expanded with items regarding alterations in scheduling and treatment plans. Data on procedures performed in 2020 were compared with those from a historical cohort (2018-2019). Endpoints included total numbers of procedures performed and altered treatment plans. Secondary endpoints included complication, readmission, and mortality rates. Results Some 12 154 procedures were performed in participating hospitals in 2020, representing a decrease of 13.6 per cent compared with 2018-2019. The largest reduction (29.2 per cent) was for non-cancer procedures during the first COVID-19 wave. Surgical treatment was postponed for 9.6 per cent of patients. Alterations in surgical treatment plans were observed in 1.7 per cent. Time from diagnosis to surgery decreased (to 28 days in 2020, from 34 days in 2019 and 36 days in 2018; P < 0.001). For cancer-related procedures, duration of hospital stay decreased (5 versus 6 days; P < 0.001). Audit-specific complications, readmission, and mortality rates were unchanged, but ICU admissions decreased (16.5 versus 16.8 per cent; P < 0.001). Conclusion The reduction in the number of surgical operations was greatest for those without cancer. Where surgery was undertaken, it appeared to be delivered safely, with similar complication and mortality rates, fewer admissions to ICU, and a shorter hospital stay.Lay Summary COVID-19 has had a significant impact on healthcare worldwide. Hospital visits were reduced, operating facilities were used for COVID-19 care, and cancer screening programmes were cancelled. This study describes the impact of the COVID-19 pandemic on Dutch surgical healthcare in 2020. Patterns of care in terms of changed or delayed treatment are described for patients who had surgery in 2020, compared with those who had surgery in 2018-2019. The study found that mainly non-cancer surgical treatments were cancelled during months with high COVID-19 rates. Outcomes for patients undergoing surgery were similar but with fewer ICU admissions and shorter hospital stay. These data provide no insight into the burden endured by patients who had postponed or cancelled operations.

Details

Language :
English
ISSN :
00071323
Volume :
109
Issue :
12
Database :
OpenAIRE
Journal :
British Journal of Surgery
Accession number :
edsair.doi.dedup.....94d39c902876cd2d5290647886861692
Full Text :
https://doi.org/10.1093/bjs/znac301